US Patent Issued to CRYONOVE PHARMA on Oct. 27 for "Cosmetic composition intended for the treatment of skin hyperpigmentation and treatment method using said composition" (French Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,773,252, issued on Oct. 27, was assigned to CRYONOVE PHARMA (Chartres, France).

"Cosmetic composition intended for the treatment of skin hyperpigmentation and treatment method using said composition" was invented by Denis Marin (L'Etang la Ville, France) and Jean-Christophe Anton (Strasbourg, France).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a cosmetic composition intended for application to the epidermis for the treatment of skin hyperpigmentation, characterized in that it comprises from 1 to 7 doses of an atomized cryogenic fluid, the boiling point of which is between -196deg C. and -19deg C., each dose measuring b...